These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1723287)

  • 61. Quantification and topographical description of Ki-67 antibody labelling during the cell cycle of normal fibroblastic (MRC-5) and mammary tumour cell lines (MCF-7).
    Guillaud P; du Manoir S; Seigneurin D
    Anal Cell Pathol; 1989 Feb; 1(1):25-39. PubMed ID: 2488698
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Immunoreactivity with monoclonal antibody A-80 and nuclear DNA content in benign and malignant human breast disease.
    Eriksson E; Schimmelpenning H; Silfverswärd C; Auer G
    Hum Pathol; 1992 Dec; 23(12):1366-72. PubMed ID: 1468773
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [The objective comparison of nuclear DNA content with nuclear grade in breast cancer].
    Yamamoto N
    Nihon Geka Gakkai Zasshi; 1995 Apr; 96(4):236-44. PubMed ID: 7753019
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Karyometric marker features in fine needle aspirates of invasive follicular carcinoma of the thyroid.
    Galera-Davidson H; Bartels PH; Fernandez-Rodriguez A; Dytch HE; Lerma-Puertas E; Bibbo M
    Anal Quant Cytol Histol; 1990 Feb; 12(1):35-41. PubMed ID: 1689162
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Application of the monoclonal antibody Ki-67 on prostate biopsies to assess the fraction of human prostatic carcinoma.
    Oomens EH; van Steenbrugge GJ; van der Kwast TH; Schröder FH
    J Urol; 1991 Jan; 145(1):81-5. PubMed ID: 1701497
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparison of DNA content in primary and lymph node metastases in prostate adenocarcinoma.
    Babiarz J; Peters JM; Miles B; Crissman JD
    Anal Quant Cytol Histol; 1993 Jun; 15(3):158-64. PubMed ID: 8347255
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparative assessment of proliferation and DNA content in breast carcinoma by image analysis and flow cytometry.
    Dawson AE; Norton JA; Weinberg DS
    Am J Pathol; 1990 May; 136(5):1115-24. PubMed ID: 1972000
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Aggressive papillary male breast carcinoma on fine-needle cytology sample.
    Zeppa P; Mascolo M; Zabatta A; Finelli L; Vetrani A; Palombini L
    Diagn Cytopathol; 2003 Dec; 29(6):360-3. PubMed ID: 14648798
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Proliferating cell nuclear antigen in needle biopsy specimens of prostatic carcinoma.
    Naito S; Sakamoto N; Kotoh S; Goto K; Koga H; Hasegawa S; Matsumoto T; Kumazawa J
    Eur Urol; 1994; 26(2):164-9. PubMed ID: 7525294
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer.
    Shah RB; Zhou M; LeBlanc M; Snyder M; Rubin MA
    Am J Surg Pathol; 2002 Sep; 26(9):1161-8. PubMed ID: 12218572
    [TBL] [Abstract][Full Text] [Related]  

  • 71. DNA ploidy in cell nuclei from paraffin-embedded material--comparison of results from two laboratories.
    Fosså SD; Berner A; Waehre H; Heiden T; Juul ME; van den Ouden D; Pettersen EO; Wang N; Tribukait B
    Cytometry; 1992; 13(4):395-403. PubMed ID: 1526198
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
    Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Combined analysis of ploidy and cell kinetics on fine-needle aspirates from breast tumors.
    Martelli G; Daidone MG; Mastore M; Gabrielli GM; Galante E; Pilotti S; Silvestrini R
    Cancer; 1993 Apr; 71(8):2522-7. PubMed ID: 8453575
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Heterogeneity of the chromatin fine structure in DNA-diploid breast cancer cells.
    Haroske G; Friedrich K; Theissig F; Meyer W; Kunze KD
    Anal Cell Pathol; 1995 Apr; 8(3):213-26. PubMed ID: 7547495
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Nucleolar prominence as a diagnostic variable in prostatic carcinoma.
    Kelemen PR; Buschmann RJ; Weisz-Carrington P
    Cancer; 1990 Feb; 65(4):1017-20. PubMed ID: 1688728
    [TBL] [Abstract][Full Text] [Related]  

  • 76. p63 protein expression is rare in prostate adenocarcinoma: implications for cancer diagnosis and carcinogenesis.
    Parsons JK; Gage WR; Nelson WG; De Marzo AM
    Urology; 2001 Oct; 58(4):619-24. PubMed ID: 11597556
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Flow cytometry analysis of the DNA content of the prostate cancer--study on the tumor heterogeneity in prostate cancer].
    Michinaga S; Ariyoshi A; Kinjo M; Sagiyama K
    Nihon Hinyokika Gakkai Zasshi; 1996 Jun; 87(6):937-41. PubMed ID: 8753013
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Single cell multiple biomarker analysis in archival breast fine-needle aspiration specimens: quantitative fluorescence image analysis of DNA content, p53, and G-actin as breast cancer biomarkers.
    Rao JY; Apple SK; Hemstreet GP; Jin Y; Nieberg RK
    Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1027-33. PubMed ID: 9829712
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Immunohistochemical study of androgen receptors in metastatic prostate cancer. Comparison of receptor content and response to hormonal therapy.
    Sadi MV; Walsh PC; Barrack ER
    Cancer; 1991 Jun; 67(12):3057-64. PubMed ID: 1710537
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Flow and image cytometric DNA measurements in fine needle aspiration samples of prostatic neoplasms.
    Piaton E; Bringuier PP; Seigneurin D; Perrin P; Devonec M
    Anal Quant Cytol Histol; 1995 Oct; 17(5):351-60. PubMed ID: 8534338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.